English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background Cancer is a dreadful disease and remains a major cause of mortality world-wide. Plant derived compounds such as vincristine, vinblastine, etoposide, camptothecin etc. are widely used in cancer therapeutics. Nigella sativa (Figure 1) is claimed to have antihypertensive, analgesic, diuretic, anti-bacterial and liver protective effects [1]; however, there are only very few scientific evidence. In the present study, we attempt to explore the anticancer cancer claims of Nigella sativa, on human hepatocellular adenocarcinoma (HepG2) cell line in vitro.

Evaluation of the effect of Nigella sativa extract on human hepatocellular adenocarcinoma cell line (HepG2) in vitro